Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
TOP SEARCHES: OCT // Canaloplasty // AMD
In this issue
Phacoemulsification fluidics
AMO withdrawal
RP modulation
Anecortave acetate out
Saving vision and lives
Thwarting corneal transplants

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Pamela Brook, editor.

Click here to contact Amelia Tope, associate editor.

Click here to contact Neil Hanley, sales manager.

Survey

Will the recent results from Novartis' combination therapy trial for AMD deter ophthalmologists from administering this regimen to AMD patients?
Novartis

Yes 57%
No 43%

 

 

JULY 8, 2009
Phaco fluidics characterized by new lab methods
Implementation of novel techniques to analyze the fluidic signature of phacoemulsification performed using different ultrasound modalities and phaco tips is providing important insights that will be helpful for improving the efficiency and safety of lens removal surgery. More...
Parasitic eye infections tied to contact lens solution
An inspection conducted by the U.S. Food and Drug Administration determined that a subsidiary of Abbott Park, Ill.-based Abbott Laboratories Inc. failed to disclose multiple reports of a serious parasitic eye infection for more than a year. More...
RP modulation with stem cells
Stemedica Cell Technologies, Inc., (Stemedica),a manufacturer and developer of clinical grade allogeneic adult stem cell technology, has discovered a significant breakthrough in the use of human stem cells and stem cell factors for the potential treatment of degenerations of the retina and retinal pigmented epithelium. More...
Alcon discontinues anecortave acetate
Alcon has discontinued development of anecortave acetate for the reduction of intraocular pressure (IOP) associated with glaucoma. More...
Glaucoma and blocked blood vessels
A study reported in the July issue of Ophthalmology, the journal of the American Academy of Ophthalmology correlates the incidence of silent cerebral infarcts (SCI) and visual field loss in patients with normal-tension glaucoma. More...
Inflammation thwarts corneal transplants in herpes patients
A further study in the July issue of Ophthalmology, the journal of the American Academy of Ophthalmology, investigated inflammation biomarkers in relation to corneal transplant rejection in herpes simplex patients. Its results have shown that inflammation thwarts corneal transplants. More...
product profile
Excimer laser for multiple applications
The ExciStar XS series from Coherent, Inc. represents a compact, economical excimer laser offering performance and lifetime characteristics. The air cooled ExciStar XS measures 0,08 m3, yet delivers pulse energies up to 12mJ at 248nm with an energy stability of <2% (1s), at repetition rates of 500 Hz. The use of Almeta XS tube design and all solid state pulser results in a product lifetime that lasts for more than 1 billion pulses than that of tube and optics. Read more...
 

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.